Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “VaIN3”

5 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 5 of 5 results

Large-scale testing (Phase 3)Looking for participantsNCT04422366
What this trial is testing

Evaluate the Efficacy, Immunogenicity and Safety of 9-valent HPV Recombinant Vaccine in Chinese Healthy Females

Who this might be right for
Cervical CancerVulvar CancerVaginal Cancer+11 more
Shanghai Bovax Biotechnology Co., Ltd. 8,000
Large-scale testing (Phase 3)Study completedNCT05372016
What this trial is testing

Evaluate the Immunogenicity and Safety of 9-valent HPV Recombinant Vaccine in Chinese Healthy Females

Who this might be right for
HPV InfectionsCervical CancerVulvar Cancer+12 more
Shanghai Bovax Biotechnology Co., Ltd. 1,200
Large-scale testing (Phase 3)Looking for participantsNCT04895020
What this trial is testing

Immunobridging Study of 9-valent Human Papillomavirus Recombinant Vaccine in Chinese Females Aged 9 to 19 Years

Who this might be right for
HPV InfectionsCervical CancerVulvar Cancer+12 more
Shanghai Bovax Biotechnology Co., Ltd. 1,200
Large-scale testing (Phase 3)Study completedNCT04425291
What this trial is testing

Evaluate the Immunogenicity and Safety of 4-valent and 9-valent HPV Recombinant Vaccine in Chinese Healthy Females

Who this might be right for
Cervical CancerVulvar CancerVaginal Cancer+11 more
Shanghai Bovax Biotechnology Co., Ltd. 1,680
Early research (Phase 1)Study completedNCT03676101
What this trial is testing

Evaluate the Safety and Primary Immunogenicity of 9-valent HPV Recombinant Vaccine in Chinese Healthy Females

Who this might be right for
Cervical CancersVulvar CancerVaginal Cancer+12 more
Shanghai Bovax Biotechnology Co., Ltd. 90